Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-14-000039
Filing Date
2014-11-14
Accepted
2014-11-14 16:52:17
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a10q-093014.htm 10-Q 652311
2 CEO CERTIFICATION ex_31-1.htm EX-31.1 16181
3 CFO CERTIFICATION ex_31-2.htm EX-31.2 16197
4 CEO CERTIFICATION ex_32-1.htm EX-32.1 6017
5 CFO CERTIFICATION ex_32-2.htm EX-32.2 6268
  Complete submission text file 0000318306-14-000039.txt   3023612

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE REPORT accp-20140930.xml EX-101.INS 394969
7 XBRL TAXONOMY SCHEMA accp-20140930.xsd EX-101.SCH 17032
8 XBRL CALCULATION LINKBASE accp-20140930_cal.xml EX-101.CAL 35615
9 XBRL DEFINITION LINKBASE accp-20140930_def.xml EX-101.DEF 95927
10 XBRL LABEL LINKBASE accp-20140930_lab.xml EX-101.LAB 243354
11 XBRL PRESENTATION LINKBASE accp-20140930_pre.xml EX-101.PRE 162101
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 141225091
SIC: 2834 Pharmaceutical Preparations